10 November 2020
SpeeDx Partners with Nepean Hospital to Develop Risk-Based COVID-19 Management Test
SpeeDx have partnered with researchers from Nepean Hospital in an exclusive agreement to commercialise a molecular test for IFI27 - a host biomarker with expression strongly correlated with disease progression...